| Name | Title | Contact Details |
|---|
Metabolic Solutions Development Company, LLC (MSDC) discovers and develops novel molecular targets and new therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company has raised nearly $55 million in support of the development of its novel therapeutic drugs, MSDC-0160 and MSDC-0602, which selectively modulate mitochondrial control of to important cellular activities, such as carbohydrate, lipid, and amino acid metabolism, that are out of balance in patients with type 2 diabetes. Such imbalances may also play a role in other diseases of aging such as Alzheimer’s disease and Parkinson’s disease, as well certain genetic diseases such as polycystic kidney disease.
Drug Transport, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
biopharmservices is a Acton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
III International is a company that offers purpose-built, Proactive Wellness products designed to create demonstrable results through maximizing bioavailability and cellular absorption. Their philosophy extends beyond their products and encompasses the...
Be a part of something bigger. Enhance your eye care practice’s capabilities by partnering with a team that understands your business. Contact us today.